Office 200 mg/200 mg Tablet is a combination antibiotic formulation containing Cefixime 200 mg and Ofloxacin 200 mg, indicated for the treatment of a variety of bacterial infections. Cefixime, a third-generation cephalosporin, exerts its bactericidal effect by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. Ofloxacin, a fluoroquinolone antibiotic, acts by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and transcription, thereby preventing bacterial proliferation. This synergistic combination enhances the antimicrobial spectrum, making Office effective against a broad range of gram-positive and gram-negative pathogens, including strains resistant to monotherapy. It is commonly prescribed for respiratory tract infections, urinary tract infections, otitis media, gonorrhea, and skin and soft tissue infections. The recommended dosage and duration of therapy should be determined by a healthcare professional based on the severity and type of infection. Caution is advised in patients with a history of hypersensitivity to cephalosporins or fluoroquinolones, and potential side effects include gastrointestinal disturbances, hypersensitivity reactions, and central nervous system effects such as dizziness or headache. Office 200 mg/200 mg Tablet should be used under medical supervision to ensure efficacy and minimize the risk of antibiotic resistance.